Medical and psychosocial aspects of fertility after cancer.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 2719717)

Published in Cancer J on February 06, 2009

Authors

Christine Duffy1, Susan Allen

Author Affiliations

1: Division of General Internal Medicine, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA. Christine_Duffy@Brown.edu

Articles cited by this

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol (2006) 11.07

Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol (2004) 4.03

Side effects of adjuvant treatment of breast cancer. N Engl J Med (2001) 3.40

Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer (1999) 3.13

Mean age of mother, 1970-2000. Natl Vital Stat Rep (2002) 2.71

Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol (2003) 2.64

Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol Oncol (2005) 2.62

Primary care for survivors of breast cancer. N Engl J Med (2000) 2.39

Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol (1999) 2.29

Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab (2006) 2.28

Fertility preservation and reproduction in cancer patients. Fertil Steril (2005) 2.27

The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update (2001) 2.25

Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation. Hum Reprod (2004) 2.15

Fertility preservation in female patients. Hum Reprod Update (2004) 2.09

Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group. Acta Oncol (2008) 1.95

Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol (2008) 1.89

Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med (1998) 1.87

Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr (2001) 1.84

Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol (2003) 1.71

Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr (2005) 1.70

Discussion of fertility preservation with newly diagnosed patients: oncologists' views. J Cancer Surviv (2007) 1.68

Tamoxifen and pregnancy. Breast (2004) 1.67

Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol (2004) 1.63

Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol (2005) 1.58

Psychosocial problems among younger women with breast cancer. Psychooncology (2004) 1.55

Psychosocial aspects of infertility and decisions about reproduction in young cancer survivors: a review. Med Pediatr Oncol (1999) 1.54

Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr (2005) 1.54

Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol (2005) 1.54

Information and service needs for young adult cancer patients. Support Care Cancer (2008) 1.51

Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecol Oncol (2005) 1.42

Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. Hum Reprod (2003) 1.41

Births: preliminary data for 2003. Natl Vital Stat Rep (2004) 1.39

Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol (2002) 1.31

Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood. Hum Reprod (2007) 1.27

Young women's experience of breast cancer: defining young and identifying concerns. Psychooncology (2000) 1.26

Health and supportive care needs of young adult cancer patients and survivors. J Cancer Surviv (2007) 1.24

Reproduction beyond cancer: a message of hope for young women. Gynecol Oncol (2006) 1.23

Radical vaginal trachelectomy (Dargent's operation): a critical review of the literature. Eur J Surg Oncol (2007) 1.23

Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update (2004) 1.21

Barriers to fertility preservation among pediatric oncologists. Patient Educ Couns (2008) 1.21

Risk and timing of counseling and support interventions for younger women with breast cancer. J Natl Cancer Inst Monogr (1994) 1.21

Physical and psychosocial functioning and adjustment to breast cancer. Long-term follow-up of a screening population. Cancer (1989) 1.20

The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study. Psychooncology (2003) 1.14

Age differences in the psychosocial problems encountered by breast cancer patients. J Natl Cancer Inst Monogr (1994) 1.14

Intrusiveness of illness and quality of life in young women with breast cancer. Psychooncology (1998) 1.12

Fertility preservation in patients with early cervical cancer: radical trachelectomy. Gynecol Oncol (2008) 1.09

Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol (1987) 1.07

Grief, depression, and coping in women undergoing infertility treatment. Obstet Gynecol (1999) 1.07

The psychosocial context of cancer-related infertility. Cancer Treat Res (2007) 1.06

Oncology nurses' perceptions of barriers to discussion of fertility preservation with patients with cancer. Clin J Oncol Nurs (2008) 1.04

Frozen-thawed embryo transfer: influence of clinical factors on implantation rate and risk of multiple conception. Hum Reprod (2001) 1.04

Having children after breast cancer. Cancer Pract (1995) 1.04

Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma (1999) 1.03

Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer (2002) 1.03

Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr (2005) 0.99

Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev (1995) 0.99

Pregnancy after breast cancer. Eur J Cancer (2003) 0.98

Preserving fertility after cancer. CA Cancer J Clin (2005) 0.97

Ovarian function preservation in the cancer patient. Fertil Steril (2004) 0.97

In vitro fertilization for cancer patients and survivors. Fertil Steril (2001) 0.93

Motivation for giving birth after breast cancer. Psychooncology (2005) 0.93

Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Gynecol Oncol (2008) 0.93

Human oocyte cryopreservation: a valid alternative to embryo cryopreservation? Eur J Obstet Gynecol Reprod Biol (2004) 0.91

Fertility options in young breast cancer survivors: a review of the literature. Oncol Nurs Forum (2004) 0.91

Ovarian rescue/protection from chemotherapeutic agents. J Soc Gynecol Investig (2001) 0.90

Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril (2007) 0.89

Research promoting better patient education on reproductive health after cancer. J Natl Cancer Inst Monogr (2005) 0.87

Childbearing issues in breast carcinoma survivors. Cancer (1997) 0.87

Fertility preservation in cancer patients using stored ovarian tissue: clinical aspects. Curr Opin Endocrinol Diabetes Obes (2008) 0.86

Prevention of gonadal damage during cytotoxic therapy. Ann Med (1997) 0.85

Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study. Anticancer Drugs (2002) 0.85

Role of conservative surgery in ovarian cancer: the European experience. Int J Gynecol Cancer (2005) 0.84

Radical vaginal trachelectomy: a fertility-preserving option for young women with early stage cervical cancer. Gynecol Oncol (2005) 0.82

Incidence of fertility counseling of women of child-bearing age before treatment for colorectal cancer. Am J Surg (2007) 0.82

Conservative management of patients with early endometrial carcinoma: a systematic review. Clin Transl Oncol (2008) 0.80

Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors. Eur J Obstet Gynecol Reprod Biol (2005) 0.80

Psychosocial and reproductive outcomes of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol (2003) 0.80

Fertility and sexuality in young cancer survivors who have adult-onset malignancies. Hematol Oncol Clin North Am (2008) 0.78

Pregnancy and breast cancer: epidemiology, treatment, and safety issues. Oncology (Williston Park) (2005) 0.76

Effect of cancer and cancer treatment on human reproduction. Expert Rev Anticancer Ther (2007) 0.76

Articles by these authors

New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet (2008) 11.20

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science (2004) 8.60

Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol (2008) 7.54

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med (2009) 7.01

Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J Virol (2006) 5.25

Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J Exp Med (2005) 4.68

Adaptation of HIV-1 to human leukocyte antigen class I. Nature (2009) 4.24

Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 4.23

Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS One (2008) 3.94

Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J Virol (2007) 3.93

Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J Virol (2007) 3.78

Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One (2009) 3.66

Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia. J Virol (2002) 3.58

Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol (2004) 3.28

Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS (2007) 3.26

Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med (2008) 3.20

Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J Virol (2006) 2.41

Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J Exp Med (2009) 2.39

Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J Virol (2002) 2.38

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa. PLoS One (2009) 2.37

Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection. J Virol (2006) 2.34

Syphilis treatment response among HIV-discordant couples in Zambia and Rwanda. Clin Infect Dis (2013) 2.22

Evolution of couples' voluntary counseling and testing for HIV in Lusaka, Zambia. J Acquir Immune Defic Syndr (2008) 2.17

Attitudes towards couples-based HIV testing among MSM in three US cities. AIDS Behav (2011) 2.09

Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa. AIDS Res Hum Retroviruses (2010) 2.05

Contraception among HIV concordant and discordant couples in Zambia: a randomized controlled trial. J Womens Health (Larchmt) (2007) 1.82

Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice. AIDS Res Hum Retroviruses (2003) 1.73

Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa. PLoS One (2010) 1.71

Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J Virol (2007) 1.70

Enrollment and retention of HIV discordant couples in Lusaka, Zambia. J Acquir Immune Defic Syndr (2008) 1.61

Indeterminate and discrepant rapid HIV test results in couples' HIV testing and counselling centres in Africa. J Int AIDS Soc (2011) 1.55

Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans. J Virol (2006) 1.52

Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J Immunol (2004) 1.50

The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter. J Virol (2010) 1.49

Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J Virol (2009) 1.40

HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. AIDS Res Hum Retroviruses (2004) 1.37

Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples. J Immunol (2008) 1.36

Knowledge, use, and concerns about contraceptive methods among sero-discordant couples in Rwanda and Zambia. J Womens Health (Larchmt) (2009) 1.35

A randomized controlled trial to promote long-term contraceptive use among HIV-serodiscordant and concordant positive couples in Zambia. J Womens Health (Larchmt) (2011) 1.30

Role of donor genital tract HIV-1 diversity in the transmission bottleneck. Proc Natl Acad Sci U S A (2011) 1.30

Influence network effectiveness in promoting couples' HIV voluntary counseling and testing in Kigali, Rwanda. AIDS (2012) 1.25

Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entry. J Virol (2010) 1.21

Safety and acceptability of couples HIV testing and counseling for US men who have sex with men: a randomized prevention study. J Int Assoc Provid AIDS Care (2013) 1.18

Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones. Virology (2012) 1.18

Promotion of couples' voluntary HIV counselling and testing in Lusaka, Zambia by influence network leaders and agents. BMJ Open (2012) 1.13

Predictors of HIV serostatus among HIV discordant couples in Lusaka, Zambia and female antenatal clinic attendants in Kigali, Rwanda. AIDS Res Hum Retroviruses (2005) 1.09

The prevalence of undiagnosed HIV serodiscordance among male couples presenting for HIV testing. Arch Sex Behav (2014) 1.09

Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes. J Acquir Immune Defic Syndr (2006) 1.07

Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection. J Virol (2012) 1.07

Factors explaining children's responses to intravenous needle insertions. Nurs Res (2010) 1.06

The complexity of implementing culture change practices in nursing homes. J Am Med Dir Assoc (2010) 1.04

Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. AIDS Res Hum Retroviruses (2005) 1.03

Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population. PLoS One (2011) 1.01

Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies. J Virol (2010) 1.01

Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples. J Infect Dis (2011) 1.01

Failure of a novel, rapid antigen and antibody combination test to detect antigen-positive HIV infection in African adults with early HIV infection. PLoS One (2012) 1.00

Prevalence of seroconversion symptoms and relationship to set-point viral load: findings from a subtype C epidemic, 1995-2009. AIDS (2012) 1.00

The hypervariable HIV-1 capsid protein residues comprise HLA-driven CD8+ T-cell escape mutations and covarying HLA-independent polymorphisms. J Virol (2010) 1.00

Racial and ethnic differences in use of assistive devices for mobility: effect modification by age. J Aging Health (2006) 0.99

Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships. PLoS One (2010) 0.98

The relationship between alcohol consumption and unprotected sex among known HIV-discordant couples in Rwanda and Zambia. AIDS Behav (2007) 0.96

Impact of long-term contraceptive promotion on incident pregnancy: a randomized controlled trial among HIV-positive couples in Lusaka, Zambia. J Acquir Immune Defic Syndr (2013) 0.95

Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes. J Virol (2011) 0.94

Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians. Retrovirology (2011) 0.93

Impact of Parent-Provided Distraction on Child Responses to an IV Insertion. Child Health Care (2010) 0.93

Local residents trained as 'influence agents' most effective in persuading African couples on HIV counseling and testing. Health Aff (Millwood) (2011) 0.92

The influence of informed consent content on study participants' contraceptive knowledge and concerns. Stud Fam Plann (2010) 0.92

Contraceptive discontinuation and switching among couples receiving integrated HIV and family planning services in Lusaka, Zambia. AIDS (2013) 0.89

HLA-DRB1 and -DQB1 alleles and haplotypes in Zambian couples and their associations with heterosexual transmission of HIV type 1. J Infect Dis (2004) 0.89

Use of complementary therapies during chemotherapy: influence of patients' satisfaction with treatment decision making and the treating oncologist. Integr Cancer Ther (2006) 0.89

Wheelchair users at home: few home modifications and many injurious falls. Am J Public Health (2002) 0.88

Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients. AIDS (2006) 0.88

Unintended pregnancy among HIV positive couples receiving integrated HIV counseling, testing, and family planning services in Zambia. PLoS One (2013) 0.88

Is the Vpr R77Q mutation associated with long-term non-progression of HIV infection? AIDS (2004) 0.88

Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays. BMC Infect Dis (2011) 0.87

Perspectives on use of mobility aids in a diverse population of seniors: implications for intervention. Disabil Health J (2009) 0.86

Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection. Virology (2010) 0.85

HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race? J Virol (2013) 0.85

HLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral load. J Infect Dis (2012) 0.83

HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection. J Clin Microbiol (2009) 0.82

Real-time PCR quantitation of subtype C HIV DNA in a Zambian discordant couple cohort. AIDS Res Hum Retroviruses (2006) 0.82

Project Eban: a giant step forward. J Acquir Immune Defic Syndr (2008) 0.81

A gp41-based heteroduplex mobility assay provides rapid and accurate assessment of intrasubtype epidemiological linkage in HIV type 1 heterosexual transmission Pairs. AIDS Res Hum Retroviruses (2012) 0.80

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions. Hum Genet (2014) 0.79

Repeat mammography screening among unmarried women with and without a disability. Womens Health Issues (2009) 0.79

Implementation and Operational Research: Evolution of Couples' Voluntary Counseling and Testing for HIV in Rwanda: From Research to Public Health Practice. J Acquir Immune Defic Syndr (2016) 0.78

Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women. J Acquir Immune Defic Syndr (2016) 0.76

Matching doses of distraction with child risk for distress during a medical procedure: a randomized clinical trial. Nurs Res (2014) 0.76

Pregnancy and HIV disease progression in an early infection cohort from five African countries. Epidemiology (2016) 0.75

Reply to Yang et al. Clin Infect Dis (2013) 0.75

Predictors of first follow-up HIV testing for couples' voluntary HIV counseling and testing in Ndola, Zambia. J Acquir Immune Defic Syndr (2014) 0.75

Susan Allen: confronting HIV in Africa. Interview by Hema Bashyam. J Exp Med (2008) 0.75

A novel 24-base pair deletion in the coding region of CCR5 in an African population. AIDS (2007) 0.75

Rare and new V3 loop variants in HIV-1-positive long-term non-progressors from Rwanda. AIDS (2002) 0.75

Pseudo-obstruction due to foreign body: importance of good physical examination. J Am Geriatr Soc (2008) 0.75

Workforce demand forecaster tool: health human resources' recruitment crystal ball? Nurs Leadersh (Tor Ont) (2010) 0.75